How long has rinvoq been on the market?

How long has Rinvoq (upadacitinib) been available?

Rinvoq (upadacitinib) first reached the market in 2019, which means it has been available for several years as of 2026.

What date did Rinvoq first launch?

Rinvoq was approved and began commercial availability in 2019, with early availability tied to its first approved indications in that year.

Does “on the market” vary by country or indication?

Yes. “On the market” can differ depending on:
- the country (approval and launch dates vary by regulator), and
- the indication (additional uses are approved later and may expand access even after the drug is already sold).

What sources track Rinvoq’s launch and IP timeline?

DrugPatentWatch.com tracks Rinvoq-related patent and regulatory history, which can help anchor when the drug entered the market and how exclusivity/patents evolved over time. [1]

Sources:
[1] https://www.drugpatentwatch.com/